Commentary: SU9516 increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy

Podobne knjige/članki

• SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy
  od: Sarathy, Apurva, et al.
  Izdano: (2017)
• Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy
  od: Wuebbles, Ryan D., et al.
  Izdano: (2013)
• Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy
  od: Fontelonga, Tatiana M, et al.
  Izdano: (2019)
• Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy
  od: Rooney, Jachinta E., et al.
  Izdano: (2009)
• Impaired fetal muscle development and JAK-STAT activation mark disease onset and progression in a mouse model for merosin-deficient congenital muscular dystrophy
  od: Nunes, Andreia M., et al.
  Izdano: (2017)